Empery Asset Management, LP and Others Report 9.99% Ownership in Theriva Biologics, Inc.

SEC Filing SCHEDULE 13G (0000902664-25-003293)

Empery Asset Management, LP, along with Ryan M. Lane and Martin D. Hoe, have filed a Schedule 13G with the SEC, reporting a 9.99% ownership in Theriva Biologics, Inc. The ownership includes common stock and warrants exercisable into common stock. The filing indicates that the Reporting Persons cannot exercise the warrants to the extent that they would beneficially own more than 9.99% of the outstanding shares due to a blocker provision. The shares are held by funds managed by Empery Asset Management, LP, and the Reporting Individuals are Managing Members of the General Partner of the Investment Manager. The filing was made pursuant to Rule 13d-1(b) and includes a joint filing agreement.